HLA locus
Showing 26 - 50 of 1,083
HLA-DQA1*05 Genotype in Anti-TNF Treatment With Proactive
Recruiting
- Drug Monitoring
- Inflammatory Bowel Diseases
- Tumor necrosis factor (TNF)-alpha inhibitors
-
Valladolid, SpainHospital Universitario Rio Hortega
Aug 8, 2023
X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)
Suspended
- X-linked Severe Combined Immunodeficiency (XSCID)
- Palifermin
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Advanced Melanoma Trial in Worldwide (IMC-F106C, Nivolumab, Nivolumab + Relatlimab)
Not yet recruiting
- Advanced Melanoma
- IMC-F106C
- +2 more
-
La Jolla, California
- +61 more
Oct 31, 2023
MPS I Trial in Oakland (SB-318)
Terminated
- MPS I
- SB-318
-
Oakland, CaliforniaUCSF Benioff Children's Hospital Oakland
Jan 6, 2023
Developmental Endothelial Locus-1, Platelet Count, and Soluble
Not yet recruiting
- Overweight and Obesity
- Platelet count
- +2 more
-
Aswan, EgyptAswan University Hospital
May 17, 2023
Cancer Colorectal Trial (a multi-locus blood-based assay)
Not yet recruiting
- Cancer Colorectal
- a multi-locus blood-based assay
- (no location specified)
Sep 7, 2022
Uveal Melanoma Trial in Pittsburgh (Tebentafusp)
Not yet recruiting
- Uveal Melanoma
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Oct 5, 2023
Pregnancy in Lung Transplantion : a National Multicentric Study
Not yet recruiting
- Lung Transplantation
- +2 more
- HLA typing of the children
- (no location specified)
Jan 16, 2023
HLA-DR in Cell Cultures Isolated From Primary Squamous Cell
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
- Cancer
- cell culture
-
Roma, Lazio, ItalyFondazione Policlinico Universitario Gemelli, Irccs
Sep 11, 2023
From Epididymal Samples to Study CFTR Gene Regulation
Not yet recruiting
- Cystic Fibrosis
- +2 more
- Epididymal sample
-
Brest, FranceAntoine VALERI
Sep 22, 2023
HLA-DQ in Acute Kidney Transplantation Rejection
Completed
- Kidney Transplantation
- HLA-DQ by luminex technology in kidney transplantation
-
Assiut, EgyptAssiut U
May 17, 2020
Diabetes, Type 1 Trial in China (HLA)
Recruiting
- Diabetes Mellitus, Type 1
- HLA
-
Quanzhou, Fujian, China
- +9 more
Oct 22, 2022
NSCLC, Head and Neck Squamous Cell Carcinoma, Colorectal Carcinoma Trial in Duarte (Autologous, engineered T Cells targeting
Not yet recruiting
- Non-small Cell Lung Cancer
- +5 more
- Autologous, engineered T Cells targeting TP53 R175H
-
Duarte, CaliforniaCity of Hope
May 17, 2023
Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical
Completed
- Multiple Myeloma
- +7 more
- Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 2, 2022
Trifecta-Lung cfDNA-MMDx Study
Recruiting
- Lung Transplantation
-
Melbourne, Australia
- +5 more
Apr 18, 2023
KRAS G12V Mutant Advanced Epithelial Cancers Trial (Cyclophosphamide, Gemcitabine, Pembrolizumab)
Available
- KRAS G12V Mutant Advanced Epithelial Cancers
- Cyclophosphamide
- +3 more
- (no location specified)
May 19, 2022
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
Recurrent Pregnancy Loss Trial in Aalborg
Recruiting
- Recurrent Pregnancy Loss
-
Aalborg, DenmarkThe Centre for Recurrent Pregnancy Loss of Western Denmark, Depa
Apr 30, 2022
Haplo-identical Transplants in Fanconi Disease
Not yet recruiting
- Fanconi Syndrome
- Blood sampling
- (no location specified)
Jun 6, 2023
Breast Cancer Trial in United States (Placebo, GLSI-100)
Recruiting
- Breast Cancer
- Placebo
- GLSI-100
-
Birmingham, Alabama
- +21 more
Jan 30, 2023
Selection of Allogeneic Hematopoietic Cell Donors Based on KIR
Active, not recruiting
- Leukemia
- KIR genotyping
- HLA genotyping
-
Tampa, Florida
- +9 more
Nov 29, 2022
Genetic Factors in CArDiovascular Diseases UsingBIOresource of
Recruiting
- Cardiovascular Diseases
- Eligibility and lifestyle restrictions check.
- +19 more
-
Cambridge, United KingdomDepartment of Public Health and Primary Care
Aug 3, 2022
Study of Eplets Matching in Kidney Transplantation
Active, not recruiting
- Kidney Transplantation
- Eplets mismatching numbers
-
Xi'an, Shaanxi, ChinaThe First Affiliated Hospital of Xi'an Jiaotong University
May 25, 2022